» Articles » PMID: 27138191

Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus

Overview
Specialty Oncology
Date 2016 May 4
PMID 27138191
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Preexisting type 2 diabetes mellitus (preDM) increases occurrence and mortality of colorectal cancer (CRC). Insulin growth factor (IGF)/insulin receptor (IR) axes play an important role in the development of both diabetes and CRC. We aimed to explore the characteristics of proteins expression in IGF/IR axes in CRC tissues with preDM. Two hundred fifty CRC patients in West China hospital were included in analysis. Among them, 125 patients had history of diabetes matched by 125 CRC without diabetes at a 1:1 ratio. Immunohistochemical staining was used to detect the expression of proteins in IGF/IR axis. More positive expression of IGF-1, IGF-1R and IR were found in CRC group with diabetes than in non-diabetes group. No difference was detected in the expression of IR substrate-1, IR substrate-2, IGF-2, IGF binding protein 3, and mammalian target of rapamycin between two groups. Multivariate analysis showed that diabetes history was associated with all of the expression of IGF-1, IGF-1R and IR, and higher T staging and lymph node metastasis were respectively independent factors of IGF-1 and IGF-1R expression in CRC patients. Besides, IGF-1 expression was positively associated with IGF-1R and IR expression in all CRC tissues, and the association of IGF-1 and IR expression seemed to be closer in diabetes group than in non-diabetes group. Higher expression of IGF-1, IGF-1R and IR proteins in CRC was associated with diabetes, suggesting IGF-1/IR signaling may play a special part in development of CRC in patients with diabetes.

Citing Articles

Exploring biomarkers and molecular mechanisms of Type 2 diabetes mellitus promotes colorectal cancer progression based on transcriptomics.

Luo S, Zhu Y, Guo Z, Zheng C, Fu X, You F Sci Rep. 2025; 15(1):4086.

PMID: 39901036 PMC: 11791047. DOI: 10.1038/s41598-025-88520-4.


Type 2 Diabetes Mellitus and Non-Metastatic Colorectal Cancer: A Retrospective Study on Survival and Toxicity Profiles.

Elabd N, Alabassy M, Seddik R, Amer A, Abdelaziz R, Sohaib A Asian Pac J Cancer Prev. 2024; 25(1):87-94.

PMID: 38285771 PMC: 10911739. DOI: 10.31557/APJCP.2024.25.1.87.


Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia.

Kasprzak A Int J Mol Sci. 2023; 24(4).

PMID: 36835075 PMC: 9959216. DOI: 10.3390/ijms24043665.


Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study.

Du Y, Zhu Y, Zhou Y, Ding J, Liu J Mol Biomed. 2022; 3(1):41.

PMID: 36484892 PMC: 9733765. DOI: 10.1186/s43556-022-00108-w.


Survival Risk Analysis of Small Cell Lung Cancer Patients with Pre-Existing Type 2 Diabetes Mellitus: A Single-Center Retrospective Cohort Study.

Ding J, Li X, Ge J, Gong Y, Zhou Y, Xiao J Cancer Manag Res. 2022; 14:1313-1322.

PMID: 35386185 PMC: 8979423. DOI: 10.2147/CMAR.S340334.


References
1.
Gallagher E, LeRoith D . The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 2010; 21(10):610-8. PMC: 2949481. DOI: 10.1016/j.tem.2010.06.007. View

2.
Zhang H, Fagan D, Zeng X, Freeman K, Sachdev D, Yee D . Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation. Oncogene. 2010; 29(17):2517-27. PMC: 2861724. DOI: 10.1038/onc.2010.17. View

3.
Sehdev A, Shih Y, Vekhter B, Bissonnette M, Olopade O, Polite B . Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population. Cancer. 2014; 121(7):1071-8. PMC: 4867231. DOI: 10.1002/cncr.29165. View

4.
Liu R, Hu L, Sun A, Cao Y, Tang T, Zhang X . mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes. Arch Med Res. 2014; 45(4):318-24. DOI: 10.1016/j.arcmed.2014.04.003. View

5.
Chen K, Shao Y, Lin Z, Yeh Y, Shau W, Kuo R . Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer. Oncologist. 2014; 19(9):951-8. PMC: 4153450. DOI: 10.1634/theoncologist.2013-0423. View